Cleerly

We're a digital healthcare company creating a world without heart attacks.

[Cleerly @Cleerlyhealth]

⏰ Tomorrow! Join Cleerly at the @MedAxiom #CVTransforum Fall '26.

We'll be offering live demos and showing how Cleerly is making the future of #cardiaccare with our AI-enabled CCTA analysis that integrates into provider workflows.

#YesCCT #Cardiology

[MedAxiom @MedAxiom]

🌐 #CVTransforum Fall ’26 is NEXT WEEK! Join us from anywhere.
Can’t make it to Denver? Register virtually to connect with cardiovascular leaders, gain practical insights and discover solutions you can bring back to your team.

As Cathie Biga shares: “You walk out with solutions you can take home. It’s not just best practices, but it’s that network that goes on outside the meeting.”

📲 Register today to join us October 22–24, in person or virtually: https://t.co/SsooEYE47Z

[Cleerly @Cleerlyhealth]

Maryland is setting a new standard by becoming the first state to require that women be notified of breast arterial calcification (BAC) found on mammograms. 👏❤️

👉 Read the full story: https://t.co/WpDitMkmq2

#WomensHealth #HeartHealth #CardiacCare

[Cleerly @Cleerlyhealth]

We’re heading to #ScientificSessions26 to share how AI-guided plaque analysis is being evaluated across the coronary artery disease spectrum.

Join us for two key sessions:

🔷 PARAMOUNT Late-Breaker

🔷 TRANSFORM Learning Studio

👉 Learn more: https://t.co/ieYTP2PYeN

#YesCCT

[Cleerly @Cleerlyhealth]

Join Dr. Fatima Rodriguez for an insightful webinar exploring the critical need for comprehensive cardiovascular risk assessment in women.

👉 https://t.co/QqgDYGKWza

#YesCCT #WomensHealth #CleerlyPartner

[Cleerly @Cleerlyhealth]

🎉 Big congratulations to our Scientific Affairs team on their late-breaking clinical trial at #ScientificSessions26!

Catch the presentation Saturday, Nov. 7 at 9:30am CT in Chicago.

👉 Learn more: https://t.co/2iPbXfvI9T

#YesCCT #AIinHealthcare

[Cleerly @Cleerlyhealth]

At #NASCI2026, we showed how Cleerly's #AI transforms complex cardiac imaging into one actionable workflow. 🫀

Thanks Dr. Sami Abuzaid for breaking down the latest clinical evidence.

Missed the presentation?

👉 Let's connect: https://t.co/x42MXNJmKO

[Cleerly @Cleerlyhealth]

By bringing our #TRANSFORM trial directly to communities with limited access to cardiac CT, we're helping make the research more representative of the patients it's meant to serve.

👉 Read the full press release: https://t.co/ymEFCrtSCA

#YesCCT #ClinicalResearch

[Cleerly @Cleerlyhealth]

Join Putri Kamila at #ACEP26 for a deep dive into the real-world implementation of Structured ED CCTA Protocols with AI-QCT Analysis.

👉 Learn more: https://t.co/GolfI3Q67o

#YesCCT #EmergencyMedicine #AIinHealthcare

[Cleerly @Cleerlyhealth]

Catch Dr. Kevin Young's session on Cleerly COMPARE, now on demand.

👉 Watch now: https://t.co/96a8MXwf0u

#YesCCT #CoronaryPlaque #Cardiology #AIinHealthcare

[Cleerly @Cleerlyhealth]

🚀 Traditional risk assessments don’t always capture the full picture of cardiovascular risk in women.

Join Dr. Rodriguez to explore how integrating clinical history and #CCTA helps reveal a more complete risk profile.

👉 https://t.co/QqgDYGKWza

#YesCCT #CleerlyPartner

[Cleerly @Cleerlyhealth]

On #WorldHeartDay, we recognize the historical gaps in cardiovascular care and reaffirm Cleerly's commitment to helping close them. 💪❤️

#DontMissABeat #HealthEquity #AIinHealthcare

[Emerj AI Research @Emerj]

Healthcare organizations improve outcomes when they can deliver confident, consistent decisions. On the #AIinBusinessPodcast, @Emerj speaks with Jim Hartman, Chief Commercial Officer at Cleerly, about how AI reduces diagnostic ambiguity and turns fragmented cardiac data into clarity clinicians can act on. Sponsored by @Cleerly: https://t.co/maJNStFtXZ

[Cleerly @Cleerlyhealth]

The first-ever @Harvard Medical School-affiliated Boston Sports Cardiology Summit kicks off today! 🫀

Connect with our team to see how Cleerly is helping advance #cardiovascularcare.

#YesCCT #AIinHealthcare #PlaqueAnalysis

[Cleerly @Cleerlyhealth]

Headed to #NASCAI2026?

Join Dr. Sami Abuzaid as he reviews the latest clinical evidence and real-world applications of Cleerly's personalized care pathway.

*Dr. Abuzaid is a paid consultant for Cleerly.

#YesCCT #Cardiology #CleerlyPartner

[Cleerly @Cleerlyhealth]

Cleerly is officially one of @TIME's "World's Top Healthtech Companies of 2026"! 🏆

Thank you to our dedicated team and trusted partners. This is a testament to how we’re fundamentally changing the way cardiovascular risk is understood and managed!

👉 https://t.co/o7uqIdOPxr

[Cleerly @Cleerlyhealth]

The most advanced cardiovascular imaging in the world still leaves physicians with a critical question: what does this mean for my patient and what can I do about it?

Cleerly can help answer that question.

👉 Learn how: https://t.co/vHfGwEpTcy

#YesCCT #CTFirst

[Cleerly @Cleerlyhealth]

🗓️ Tomorrow! Real cases. Real questions answered live.

Join Dr. Kevin Young on tracking plaque change over time with Cleerly COMPARE.

👉 Register now: https://t.co/KFzQGYbjEg

#YesCCT #PlaqueAnalysis #Cardiology

[Cleerly @Cleerlyhealth]

🚀 Our customized reports help eliminate repetitive manual edits so you can spend less time formatting reports and more time focused on patients and life outside the hospital.

See what's possible.

👉 Request a demo: https://t.co/NTWY1j18v4

#YesCCT #AIinHealthcare

[Cleerly @Cleerlyhealth]

Join our Chief Medical, Science, and AI Officer, Udo Hoffmann, MD, at #ISCT2026 to see how Cleerly's advanced plaque analysis elevates #CCTA to help proactively transform #cardiaccare.

👉 Learn more: https://t.co/JAt2OcUZl8

#YesCCT #AIinHealthcare

[Cleerly @Cleerlyhealth]

Plaque changes over time. Shouldn't your treatment approach?

With Cleerly COMPARE, the longitudinal analysis is automated, providing precise, side‑by‑side comparisons to inform your clinical decisions.

👉 Learn how: https://t.co/iNiZOAINl2

#YesCCT #CTFirst #AIinHealthcare